F2‐01‐01: Oligodendrocyte‐Enriched Gene Networks Reveal Novel Pathways and Key Targets in the Pathogenesis of Alzheimer’s Disease

Bin Zhang,Andrew McKenzie,Minghui Wang,Igor Katsyv,Won-min Song,Xianxiao Zhou,Brian Popko,Joshua Aaker,Kelly Tredici,Klaus-Armin Nave,Jun Zhu,Eric Schadt,Patrizia Casaccia

DOI: https://doi.org/10.1016/j.jalz.2016.06.380

2016-01-01

Alzheimer s & Dementia

Abstract:A growing collection of evidence exists to support a role for non-neuronal cells in Alzheimer’s Disease (AD) pathogenesis. Although less widely studied, neuroimaging and neuropathology data suggests that dysregulation of oligodendrocytes (OLs) and subsequent dysmyelination of axons appears to be a critical initiating event in stimulating AD pathology. Despite these intriguing preliminary data, the precise molecular networks and genetic targets in OLs that are involved in initiating the AD process have yet to be elucidated. We applied a series of molecular network analysis techniques to a large data set of human postmortem gene expression data from AD patient brain samples, including coexpression networks, causal Bayesian networks, key driver analysis, and network annotation tools. This integrative network approach allowed us to integrate data from a diverse set of modalities and thereby identify critical pathways and genes that are altered within OLs in AD. We find that an AD coexpression network of OL-associated genes is not only highly correlated with AD pathological traits but also enriched for the known AD GWAS risk genes. Further, we demonstrate that this network is strongly dysregulated at the expression level in brain samples from AD patients. We further dissect the molecular regulation patterns of OLs in AD to identify key drivers of the OL network including PSEN1, UGT8, CNP, MYRF, and PLP1. We show that in vitro and in vivo perturbations of the key drivers within the gene-gene interaction network mimic key aspects of gene expression dysregulation in human AD brain samples. Our data also suggests PSEN1, whose mutations have been identified in early-onset familial AD, plays a key role in the dys-regulation of myelination in the more common late-onset AD. Our network analysis of oligodendrocytes in AD further strengthens the existing evidence that OLs play a role in AD. Importantly, our results also suggest key pathways through which OLs may help mediate AD pathogenesis.